{"schema_version":"1","generated_at":"2026-10-30T05:35:40.946Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nicholas-sanfilippo","json_url":"https://www.findmykol.com/kol/nicholas-sanfilippo/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nicholas-sanfilippo","name":"Nicholas Sanfilippo","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"NYU Langone Health","institution_url":"https://www.findmykol.com/institution/nyu-langone-health","city":"New York","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1902807779","openalex":"A5108269083"},"summary":"Nicholas Sanfilippo is an Oncology physician affiliated with NYU Langone Health. OpenAlex indexes 64 publications with 1,543 citations (h-index 21); ClinicalTrials.gov lists 2 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":64,"cited_by_count":1543,"h_index":21,"latest_activity_year":2026,"source":"works"},"trials":{"count":2,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT02911350","title":"Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer","phase":"PHASE1","status":"COMPLETED","role":"Overall official","sponsor":"NYU Langone Health","source_url":"https://clinicaltrials.gov/study/NCT02911350","trial_url":"https://www.findmykol.com/trial/NCT02911350"},{"nct":"NCT01677845","title":"Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer","phase":"PHASE1","status":"TERMINATED","role":"Overall official","sponsor":"NYU Langone Health","source_url":"https://clinicaltrials.gov/study/NCT01677845","trial_url":"https://www.findmykol.com/trial/NCT01677845"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":2,"shown":2,"withheld":0,"rows":[{"payer":"Genentech USA, Inc.","program_year":2024,"amount_usd":124.73,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902807779"},{"payer":"Siemens Medical Solutions USA, Inc.","program_year":2023,"amount_usd":146.05,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1902807779"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1902807779","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2016,"last":2016},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R34DE025085","title":"Commensal Oral Microbiota as a Trigger of Oral Mucositis Severity","fiscal_year":2016,"amount_usd":"267027","organization":"NEW YORK UNIVERSITY SCHOOL OF MEDICINE","source_url":"https://reporter.nih.gov/quickSearch/R34DE025085"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy as Bladder-sparing Treatment for Muscle-invasive Urothelial Cancer of the Bladder: A Multicenter Phase 2 Trial","year":2026,"journal":"European Urology","source_url":"https://doi.org/10.1016/j.eururo.2026.02.016","status":"verified"},{"title":"Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non–small cell lung cancer","year":2025,"journal":"Journal of Thoracic and Cardiovascular Surgery","source_url":"https://doi.org/10.1016/j.jtcvs.2025.07.014","status":"verified"},{"title":"Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial","year":2024,"journal":"Nature Communications","source_url":"https://doi.org/10.1038/s41467-023-44575-3","status":"verified"},{"title":"Multicenter randomized phase II study of short course FOLFOX + nivolumab (Nivo) followed by maintenance Nivo +/- radiation (RT) in the first line treatment of metastatic or unresectable gastroesophageal adenocarcinoma (mGEA).","year":2024,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2024.42.16_suppl.4060","status":"verified"},{"title":"MRI-LINAC: A transformative technology in radiation oncology","year":2023,"journal":"Frontiers in Oncology","source_url":"https://doi.org/10.3389/fonc.2023.1117874","status":"verified"}],"source":"works"},"contact":{"address_1":"160 E 34TH ST","address_2":"LL","city":"New York","state":"NY","zip":"100164750","phone":"212-731-5003","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1902807779","source":"identity"},"similar":[{"name":"Gareth Morgan","slug":"gareth-morgan","institution":"NYU Langone Health","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/gareth-morgan","json_url":"https://www.findmykol.com/kol/gareth-morgan/profile.json"},{"name":"Nathan Levin","slug":"nathan-levin","institution":"NYU Langone Health","specialty":"Nephrology","url":"https://www.findmykol.com/kol/nathan-levin","json_url":"https://www.findmykol.com/kol/nathan-levin/profile.json"},{"name":"Ira Jacobson","slug":"ira-jacobson","institution":"NYU Langone Health","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/ira-jacobson","json_url":"https://www.findmykol.com/kol/ira-jacobson/profile.json"},{"name":"Michael Zelefsky","slug":"michael-zelefsky","institution":"NYU Langone Health","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/michael-zelefsky","json_url":"https://www.findmykol.com/kol/michael-zelefsky/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2011-11-10","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}